Two cases of pulmonary infection due to strains of multidrug-resistant Klebsiella pneumoniae were investigated. Beta-lactamase determinants, such as bla IMP-4 and bla , and the 16S rRNA methyltransferaseencoding gene armA were detected in these plasmid-bearing organisms. The integron-borne bla IMP-4 and armA contained intervening sequences highly related to those of a Vibrio cholerae O139 plasmid found in Hangzhou, China.
Two cases of pulmonary infection due to strains of multidrug-resistant Klebsiella pneumoniae were investigated. Beta-lactamase determinants, such as bla IMP-4 and bla SHV-12 , and the 16S rRNA methyltransferaseencoding gene armA were detected in these plasmid-bearing organisms. The integron-borne bla IMP-4 and armA contained intervening sequences highly related to those of a Vibrio cholerae O139 plasmid found in Hangzhou, China.
Klebsiella pneumoniae isolates producing extended-spectrum ␤-lactamases (ESBLs), particularly with the determinant bla , have been extensively reported in China (15, 16) . The use of carbapenems as the treatment of last resort for ESBL producers has contributed to the emergence of carbapenemase-producing organisms, such as Pseudomonas aeruginosa, Acinetobacter spp., and members of the Enterobacteriaceae (11) . The plasmid-carried and integron-borne class A enzyme determinant bla KPC , and class B metallo-␤-lactamase determinants bla IMP and bla VIM , as well as the aminoglycoside resistance gene armA, have been characterized (3, 11, 14) . For this report, two multidrug-resistant K. pneumoniae clinical isolates containing multiple plasmids and multiple resistance gene determinants were analyzed.
Two 6-month-old infants with congenital heart disease were admitted to Shanghai Children's Medical Center for treatment of pulmonary infections in November 2005 and January 2006. Their hospital stays did not overlap. Prior to initial microbiological evaluation, these patients were treated with oxacillin, cefuroxime, cefotaxime (CTX), ceftazidime (CAZ), cefoperazone-sulbactam, and meropenem (MEM). Multidrug-resistant isolates of K. pneumoniae (one from each patient, designated KpSCMC1 and KpSCMC2) were recovered from tracheal aspirates. Antibiotic susceptibilities were determined initially with the Vitek system (bioMérieux), and multidrug resistance patterns were further evaluated by the disk diffusion and Etest (Biomérieux) MIC method using standard interpretive criteria (5) . Both isolates showed similar susceptibility results, which included resistance to all cephalosporins and aminoglycosides (Table 1) . It was of interest that the zones of inhibition to imipenem (IMP) measured 21 mm for both isolates but the zones of inhibition to MEM measured 13 mm and 14 mm.
Given the criterion of Ն16 mm for "susceptible" to MEM and IMP by disk diffusion, both isolates were further tested by Etest. KpSCMC1 and KpSCMC2 produced MICs to IMP of 3 mg/liter and 2 mg/liter and to MEM of 8 mg/liter and 4 mg/ liter, respectively, bordering precariously on the breakpoint of Յ4 mg/liter for susceptible. Both isolates were sensitive to ciprofloxacin, although KpSCMC2 was resistant to nalidixic acid (NAL). Their susceptibilities to trimethoprim-sulfamethoxazole appeared to be chiefly due to susceptibility to trimethoprim alone, but not to sulfonamides.
Potential gene determinants associated with these resistance phenotypes were further investigated by PCR and nucleotide sequencing using previously published primers (1, 8, 11) . PCR amplification from plasmid DNA preparations of KpSCMC1 and KpSCMC2 yielded corresponding products for int1, bla IMP , bla SHV , bla TEM , armA, and sul1, but not for bla CTX-M , bla CMY , or qnr. Sequencing of the amplified products revealed the presence of bla , bla , bla TEM-1 , and armA in both isolates.
The resistance gene organization and environments were further resolved by overlapping PCR techniques. The bla IMP-4 -containing plasmids identified in both isolates appeared identical in their complex integron structures as carriers of antimicrobial resistance genes. The gene determinants were organized in the order of int1-bla IMP-4 -orfII-orfIII-qacE⌬1-sul1-orf5-orf6-orf513 (or ISCR)-tnp-Acp1-armA (GenBank FJ384365). A segment of DNA encoding both OrfII (a putative reverse transcriptase) and OrfIII (a conserved hypothetical protein) was found to contain sequence similarity to a cognate segment (GenBank EU116440) described in a plasmid (pMR150) isolated from a Vibrio cholerae O139 strain in Hangzhou, China (9) . This similarity in corresponding regions was found both at the DNA level (88% nucleotide identity), over a 1.5-kb segment, and at the deduced amino acid level (93% identity over 392 OrfII residues). Based on a GenBank search, only one other integron-borne orfII region showed a close match at the DNA level (85% nucleotide identity), over a 1.2-kb fragment (GenBank AY204504) in two Salmonella enterica serovar Typhimurium strains (DT208) isolated from retail meat in the United States (4).
It was of note that the parent strain KpSCMC2 gave rise to a fully carbapenem-sensitive segregant after unintentional in vitro passages, which was thus designated KpSCMC2c (carbapenemase-cured phenotype). Strain KpSCMC2c exhibited a characteristic ESBL phenotype with much reduced MICs to IMP (0.064 mg/liter) and MEM (0.25 mg/liter) and was fully susceptible to all aminoglycosides (Table 1) . Strain KpSCMC2c was PCR positive only for bla TEM-1 and bla and was negative for int1, bla IMP , orf513, and armA, suggesting that bla was not located on the same plasmid with the int1 cluster and thus did not cosegregate with the int1 integronborne resistance genes. Strain KpSCMC2c evidently retained its parental NAL resistance phenotype, likely due to a chromosomal mutation(s) which has been commonly documented in the quinolone resistance-determining regions of gyrA and/or parC (2). By genetic fingerprinting using pulsed-field gel electrophoresis, KpSCMC1 was found to be unrelated to KpSCMC2 and KpSCMC2c, while the latter two were indistinguishable (Fig. 1) .
Similar to results in previous reports (6, 7), the two K. pneumoniae isolates in this study showed decreased susceptibilities to MEM but troublesome initial "susceptible" results to IMP by both disk diffusion and Etest. Given the MIC susceptibility breakpoint of Յ4 mg/liter for both MEM and IMP, routine susceptibility testing using automated instrumentation may fail to detect such resistance. As with the false-negative results using Etest MBL strips to characterize metallo-␤-lactamase production, we agree with others that Enterobacteriaceae isolates showing an IMP MIC of Ն2 mg/liter should be checked for carbapenem resistance (7, 10, 13, 17) .
In summary, this study investigated two K. pneumoniae clinical isolates that showed multidrug resistance to ␤-lactam and aminoglycoside antimicrobial drug classes, together with the emergence of quinolone resistance in the second isolate. Integron-borne gene cassettes featuring int1 and/or ISCR are remarkably versatile in trapping multidrug-resistance genes, which has resulted in some untreatable "superbugs" (11, 12) . The identification of a putative reverse transcriptase (OrfII) coding sequence that is highly related to those reported in a V. cholerae O139 strain from a nearby province, together with the coexistence of bla IMP-4 -armA, raises the possibility that active dissemination of resistance genes may proceed by means of capturing recombinant elements of all kinds. Moreover, the finding of bla SHV-12 on a separate plasmid, together with what is likely a chromosomal quinolone resistance-determining region mutation(s) in strain KpSCMC2, illustrates the magnitude of the genetic capacity in these organisms when encountering antimicrobial pressure in compromised human hosts. The emergence of multidrug resistance in an otherwise commensal enteric colonizer is an operational conundrum for a pediatric surgery center where the patient population is especially vulnerable. This also represents a serious diagnostic challenge for microbiology laboratories, as well as challenges for infection control and antimicrobial drug management.
Nucleotide sequence accession number. The sequence of the bla IMP-4 -containing plasmid was submitted to GenBank under accession no. FJ384365.
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